Matthew G. Gipson

679 total citations
22 papers, 488 citations indexed

About

Matthew G. Gipson is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Matthew G. Gipson has authored 22 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Matthew G. Gipson's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Complement system in diseases (3 papers) and Renal cell carcinoma treatment (2 papers). Matthew G. Gipson is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Complement system in diseases (3 papers) and Renal cell carcinoma treatment (2 papers). Matthew G. Gipson collaborates with scholars based in United States, United Kingdom and France. Matthew G. Gipson's co-authors include V. Michael Holers, Joel M. Guthridge, Liudmila Kulik, Mitchell Smith, Terez Shea‐Donohue, George C. Tsokos, Sherry D. Fleming, Thomas J. Waldschmidt, Kimi Kondo and Paul J. Rochon and has published in prestigious journals such as The Journal of Immunology, Biochemistry and Radiographics.

In The Last Decade

Matthew G. Gipson

20 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew G. Gipson United States 11 228 177 100 69 65 22 488
Takao Nagashima Japan 14 266 1.2× 176 1.0× 44 0.4× 41 0.6× 78 1.2× 53 646
Hannah Gilligan United States 6 196 0.9× 70 0.4× 103 1.0× 35 0.5× 87 1.3× 16 446
Т. М. Reshetnyak Russia 12 105 0.5× 125 0.7× 58 0.6× 31 0.4× 52 0.8× 98 513
Sang Hyun Hwang South Korea 12 52 0.2× 87 0.5× 77 0.8× 98 1.4× 50 0.8× 36 354
Na Xu China 11 62 0.3× 106 0.6× 110 1.1× 40 0.6× 35 0.5× 44 452
Brendan Clark United Kingdom 13 217 1.0× 173 1.0× 65 0.7× 28 0.4× 11 0.2× 33 567
Norma Nardi Spain 10 137 0.6× 93 0.5× 164 1.6× 33 0.5× 89 1.4× 14 634
M Lacombe France 13 174 0.8× 218 1.2× 241 2.4× 33 0.5× 19 0.3× 66 570
Janto Surachno Netherlands 15 118 0.5× 221 1.2× 134 1.3× 52 0.8× 15 0.2× 21 583
Cheng Lay Teh Malaysia 12 275 1.2× 34 0.2× 58 0.6× 57 0.8× 54 0.8× 35 693

Countries citing papers authored by Matthew G. Gipson

Since Specialization
Citations

This map shows the geographic impact of Matthew G. Gipson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew G. Gipson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew G. Gipson more than expected).

Fields of papers citing papers by Matthew G. Gipson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew G. Gipson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew G. Gipson. The network helps show where Matthew G. Gipson may publish in the future.

Co-authorship network of co-authors of Matthew G. Gipson

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew G. Gipson. A scholar is included among the top collaborators of Matthew G. Gipson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew G. Gipson. Matthew G. Gipson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hatoum, Hassan, Alexander S. Rosemurgy, J. Augusto Bastidas, et al.. (2024). Treatment of locally advanced pancreatic cancer using localized trans-arterial micro perfusion of gemcitabine: combined analysis of RR1 and RR2. The Oncologist. 29(8). 690–698.
2.
Hohenwalter, Eric J., Matthew G. Gipson, Waddah B. Al‐Refaie, et al.. (2019). ACR Appropriateness Criteria® Radiologic Management of Biliary Obstruction. Journal of the American College of Radiology. 16(5). S196–S213. 7 indexed citations
3.
Knuttinen, M. Grace, Eric J. Hohenwalter, D.A. Bradley, et al.. (2018). ACR Appropriateness Criteria ® Radiologic Management of Uterine Leiomyomas. Journal of the American College of Radiology. 15(5). S160–S170. 9 indexed citations
4.
Gipson, Matthew G., Mitchell Smith, Janette D. Durham, et al.. (2016). Intravascular US–Guided Portal Vein Access: Improved Procedural Metrics during TIPS Creation. Journal of Vascular and Interventional Radiology. 27(8). 1140–1147. 35 indexed citations
5.
Abrams, Ross A., Waddah B. Al‐Refaie, Nilofer S. Azad, et al.. (2016). ACR Appropriateness Criteria Radiologic Management of Hepatic Malignancy. Journal of the American College of Radiology. 13(3). 265–273. 11 indexed citations
6.
Chapman, Brandon C., Alessandro Paniccia, Douglas M. Overbey, et al.. (2016). Efficacy of fibrin glue therapy for abscess-associated enteric fistulas. Techniques in Coloproctology. 20(9). 641–646.
7.
Gipson, Matthew G., et al.. (2015). Acute Pancreatitis after Transarterial Chemoembolization of Hepatocellular Carcinoma with Drug-Eluting Beads. Seminars in Interventional Radiology. 32(1). 18–21. 2 indexed citations
8.
Lorenz, Jonathan M., Waddah B. Al‐Refaie, Brooks D. Cash, et al.. (2015). ACR Appropriateness Criteria Radiologic Management of Infected Fluid Collections. Journal of the American College of Radiology. 12(8). 791–799. 11 indexed citations
9.
Gipson, Matthew G., et al.. (2015). Skin Necrosis Resulting from Nontarget Embolization of the Falciform Artery during Transarterial Chemoembolization with Drug-Eluting Beads. Seminars in Interventional Radiology. 32(1). 22–25. 5 indexed citations
10.
Rochon, Paul J., Kimi Kondo, Matthew G. Gipson, et al.. (2014). Peripheral applications of glue - a primer for the interventional radiologist. Journal of Vascular and Interventional Radiology. 25(3). S188–S189. 1 indexed citations
11.
Smith, Mitchell & Matthew G. Gipson. (2013). Endovascular Therapies for Primary Postpartum Hemorrhage: Techniques and Outcomes. Seminars in Interventional Radiology. 30(4). 333–339. 15 indexed citations
12.
Ray, Charles E., Mitchell Smith, Stephen Leong, et al.. (2013). Metaanalysis of Survival, Complications, and Imaging Response following Chemotherapy-based Transarterial Therapy in Patients with Unresectable Intrahepatic Cholangiocarcinoma. Journal of Vascular and Interventional Radiology. 24(8). 1218–1226. 65 indexed citations
13.
Gipson, Matthew G. & Kimi Kondo. (2013). Management of Lymphoceles after Renal Transplant: Case Report of a Novel Percutaneous Image-guided Treatment Technique. Journal of Vascular and Interventional Radiology. 24(6). 881–884. 2 indexed citations
14.
Gipson, Matthew G.. (2013). Percutaneous Management of Lymphoceles after Renal Transplantation. Seminars in Interventional Radiology. 30(2). 215–218. 3 indexed citations
15.
Gipson, Matthew G., Kristopher W. Cummings, & Kyle Hurth. (2009). Bronchial Atresia. Radiographics. 29(5). 1531–1535. 31 indexed citations
16.
Marchbank, Kevin J., Liudmila Kulik, Matthew G. Gipson, B. Paul Morgan, & V. Michael Holers. (2002). Expression of Human Complement Receptor Type 2 (CD21) in Mice During Early B Cell Development Results in a Reduction in Mature B Cells and Hypogammaglobulinemia. The Journal of Immunology. 169(7). 3526–3535. 26 indexed citations
17.
Fleming, Sherry D., Terez Shea‐Donohue, Joel M. Guthridge, et al.. (2002). Mice Deficient in Complement Receptors 1 and 2 Lack a Tissue Injury-Inducing Subset of the Natural Antibody Repertoire. The Journal of Immunology. 169(4). 2126–2133. 149 indexed citations
18.
Guthridge, Joel M., Kendra A. Young, Matthew G. Gipson, et al.. (2001). Epitope Mapping Using the X-Ray Crystallographic Structure of Complement Receptor Type 2 (CR2)/CD21: Identification of a Highly Inhibitory Monoclonal Antibody That Directly Recognizes the CR2-C3d Interface. The Journal of Immunology. 167(10). 5758–5766. 52 indexed citations
19.
Guthridge, Joel M., Kendra A. Young, Mohammed Aslam, et al.. (2001). Structural Studies in Solution of the Recombinant N-Terminal Pair of Short Consensus/Complement Repeat Domains of Complement Receptor Type 2 (CR2/CD21) and Interactions with Its Ligand C3dg. Biochemistry. 40(20). 5931–5941. 48 indexed citations
20.
Guthridge, Joel M., Kendra A. Young, Matthew G. Gipson, et al.. (2000). Novel inhibitory monoclonal antibodies to human CR2/CD21 ligand binding domains. Immunopharmacology. 49(1-2). 69–69. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026